Navigation Links
Enox Biopharma, Inc. Will Present at IN3 East Investment in Innovation Conference
Date:6/21/2011

VANCOUVER, British Columbia, June 21, 2011 /PRNewswire/ -- Enox Biopharma, Inc. CEO, John C. Rewcastle, Ph.D., will present at the IN3 East Investment in Innovation Conference on Wednesday, June 22 at 12:15 AM EST. The conference is being held at the Hyatt Regency Hotel in Boston.

The IN3 East meeting, hosted by Elsevier, is a medtech industry forum and networking meeting. The meeting is designed to provide exposure and constructive interaction between emerging medical innovation companies like Enox Biopharma and both venture capitalists and large device manufacturers.

Dr. Rewcastle will present Enox's technology whose foundation is the patent protected ability to embed nitric oxide into polymers which renders medical devices antimicrobial. He will also review recently filed intellectual property that expands Enox's technology to cover the wound healing space.

"One of the most significant problems facing the worldwide medical establishment is hospital acquired infections. In the United States alone, these infections drain an estimated $30-45 billion dollars per year. Enox is uniquely positioned to address this problem with its antimicrobial technology which utilizes nitric oxide as the mechanism of action. Nitric oxide is an ideal antimicrobial agent as it is very effective but does not have resistance issues like antibiotics do."

"The IN3 East Conference represents a great opportunity," continued Rewcastle. "Enox will be attractive to both the venture capitalists and potential strategic partners in attendance. Our breakthrough technology has the potential of meeting the needs of hospitals worldwide who are currently underserved by existing infection prevention technology. I anticipate a positive response to our presentation and presence at this event."

About Enox Biopharma, Inc.

Enox Biopharma, Inc. is an emerging biotechnology company with proprietary methods to sequester nitric oxide (NO) into polymers. The innate immune system uses NO to block microbial growth - embedding NO into medical devices makes them antimicrobial. NO is also an effective vasodilator which can lead to accelerated wound healing. Enox's device technology is applicable to any indwelling polymer medical device including, but not limited to catheters, endotracheal tubes and central venous catheters. Infections from these devices, which are often not reimbursed by Medicare, represent a massive financial burden to healthcare systems worldwide.

For more information, please contact:

John C. Rewcastle, Ph.D, CEO or
Itamar David, CFO
Enox Biopharma, Inc.
604.637.9744 phone

888.224.7259 fax
info@enoxbiopharma.com
www.enoxbiopharma.com


'/>"/>
SOURCE Enox Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Enox Biopharma, Inc. Will Be Granted a Patent for the Delivery of Therapeutic Agents From Within Medical Devices
2. PDL BioPharma, Inc. Prices Offering of $135.0 Million of Convertible Senior Notes Due 2015
3. Plato BioPharma, Inc. Sponsors Novel Disease Model Award
4. Enox Biopharma, Inc. to Present at IN3 West Investment in Innovation Conference.
5. Plato BioPharma, Inc Appoints New Board Member
6. Enox Biopharma, Inc. to Present at OneMedForum Emerging Company Finance Conference.
7. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Receives New Research Grant From Hong Kong Innovation and Technology Commission
8. Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug
9. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
10. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
11. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2020)... ... 27, 2020 , ... The GHT Companies , a leading developer and ... Feeding San Diego with a press conference at its manufacturing facility in Vista. ... of $5,000.00+ representing an overall donation result exceeding $30,000 to Feeding San Diego, Who: ...
(Date:8/26/2020)... ... 2020 , ... AseptiScope, a privately funded San Diego, California based, clinical innovation ... Outlook. , “AseptiScope is pleased to receive this recognition,” said Kelly Powers, ... on their hands, goggles on their eyes, covers on their shoes, and gowns on ...
(Date:8/26/2020)... Tenn. (PRWEB) , ... August 26, 2020 , ... ... commercial and in-home air purification systems kill Coronavirus. While air purification technologies, including ... viruses including SARS and even Ebola, no air purification system has published results ...
Breaking Medicine Technology:
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... intended to improve outcomes for patients with advanced heart failure, today announced that ... grant in the amount of $555,358 from the National Heart, Lung, and Blood ...
(Date:8/28/2020)... ... 2020 , ... Ernst & Young LLP (EY US) today ... The Year® 2020 Florida Award finalist. Now in its 34th year, the Entrepreneur ... and prosperity as they build and sustain successful businesses that transform our world. ...
(Date:8/28/2020)... Calif. (PRWEB) , ... August 28, 2020 , ... ... cover a one-year subscription to a customized Lighthouse Health & Wellness mobile app ... support of this project. Motorola Solutions Foundation awards grants each year to organizations, ...
(Date:8/28/2020)... ... August 28, 2020 , ... Integrated Viral Protection ... the first Florida school to deploy its breakthrough Mobile Biodefense Indoor Air Protection System ... True North Classical Academy plans to fully reopen equipped with the filtration system on ...
(Date:8/28/2020)... , ... August 28, 2020 , ... ... observations that strongly suggest that obese individuals are at an increased risk of ... any more likely to catch COVID-19; however, because the same organ systems that ...
Breaking Medicine News(10 mins):